Copyright
©The Author(s) 2000.
World J Gastroenterol. Jun 15, 2000; 6(3): 324-325
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.324
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.324
Table 2 Furazolidone dual therapy
| Authors | Furazolidone | Antibiotics | Eradication (%) | Side effect |
| Xiao SD[6] | 100 qid × 14 | CBS 120 qid × 14 | 66/90 (73) | |
| Mao PJ[7] | 100 tid × 28 | Ran 150 bid × 28 | 10/17 (59) | 8.9% |
| Mao PJ[7] | 100 tid × 28 | Ome 20 qd × 28 | 15/18 (83) | |
| Li YN[8] | 200 tid × 7 | CBS 110 qid × 28 | 34/34 (100) | |
| 100 qid × 7 | ||||
| Li YN[8] | 100 tid × 14 | CBS 110 qid × 28 | 21/23 (91) | |
| Li YN[8] | 50 tid × 14 | CBS 110 qid × 28 | 13/21 (62) | |
| Xi BG[9] | 200 tid × 14 | CBS 110 qid × 28 | 24/24 (100) |
- Citation: Li YY, Sha WH. Treatment of Helicobactor pylori infection: analysis of Chinese clinical trials. World J Gastroenterol 2000; 6(3): 324-325
- URL: https://www.wjgnet.com/1007-9327/full/v6/i3/324.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i3.324